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Upon completion of this activity, participants will be able to:

-   Identify properties of *Alcaligenes xylosoxidans*.

-   Describe the clinical presentation of *A. xylosoxidans* infection in the current study.

-   Specify risk factors for infection with *A. xylosoxidans*.

-   Identify the primary source of infection with *A. xylosoxidans* in the current study.
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CME Questions
=============

1.  Which of the following statements about *Alcaligenes xylosoxidans*is most accurate?

    1.  A. *A. xylosoxidans*is gram-positive

    2.  B. *A. xylosoxidans*is hydrophobic

    3.  C. *A. xylosoxidans*is associated with healthcare-associated infections

    4.  D. *A. xylosoxidans*is found only in soil

2.  Which of the following statements about the clinical presentation of *A xylosoxidans* infection in the current study is most accurate?

    1.  A. No patients with *A. xylosoxidans*infection were immunocompromised

    2.  B. Patients with *A. xylosoxidans*were homogeneous with regard to age and clinical diagnosis

    3.  C. Patients with *A. xylosoxidans*infection had symptoms that were attributed to side effects of chemotherapy

    4.  D. Only 10% of patients with *A. xylosoxidans*infection were successfully treated with antibiotics

3.  Which of the following factors was most different in comparing case-patients and control groups in the current study?

    1.  A. Case-patients with *A. xylosoxidans*infection had a lower mean white blood cell count compared with controls

    2.  B. Case-patients with *A. xylosoxidans*infection were more likely to have a central venous catheter compared with controls

    3.  C. Case-patients with *A. xylosoxidans*infection had a greater number of intravenous medications administered compared with controls

    4.  D. Case-patients with *A. xylosoxidans*infection had more underlying diseases compared with controls

4.  Which of the following sources was most likely the primary reservoir of *A. xylosoxidans* in the current study?

    1.  A. Tap water

    2.  B. Mixing hood

    3.  C. Hospital personnel

    4.  D. Multidose vials of heparin and saline flushes
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